Courses

Antisense Therapeutics for the Optimal Treatment of Patients with Spinal Muscular Atrophy

Program Overview

This CME program will outline current and emerging antisense therapeutics for the treatment of patients with spinal muscular atrophy (SMA). Dr. Basil Darras and Dr. John Brandsema will discuss the importance of early diagnosis and presymtomatic treatment in SMA. Current clinical trial data of available therapies for SMA will be analyzed. The expert faculty will relay best practices ...
View Course
Acute lymphoblastic leukemia, 3D illustration showing abundant lymphoblasts in blood

An In-depth Update on the Management of Acute Lymphoblastic Leukemia

Program Overview

This CME/CNE program will provide a comprehensive update of best practices for treating and managing patients with acute lymphoblastic leukemia (ALL). The expert faculty will outline molecular mutations and patient prognosis, including the t-acute lymphoblastic leukemia and the b-acute lymphoblastic leukemia subtypes. Current clinical trial data will be analyzed, particularly recent breakthroughs in the care of adults with ...
View Course
Futuristic design element

A Scientific Overview of the Management of Patients with Thyroid Eye Disease

Program Overview

This CME activity will review recent advances in the management of patients with thyroid eye disease (TED) as presented at the International Thyroid Eye Disease Society (ITEDS) 2019 Symposium in Singapore. The expert faculty will discuss the burden of disease for patients with thyroid eye disease, and review the pathophysiology of TED. The faculty will also discuss the ...
View Course
shutterstock_480361945

Advances in the Management of Patients with Atopic Dermatitis

Program Overview

This CME program will highlight recent advanced in the management of patients with atopic dermatitis. Adaobi Nwaneshiudu Obasi, MD, PhD will give a comprehensive review of current clinical trial data of therapeutic options for the treatment of atopic dermatitis. Dr. Obasi will also discuss how to develop effective management strategies with the healthcare team to improve outcomes for patients with atopic dermatitis ...
View Course
Screen Shot 2019-03-29 at 10.14.06 AM

Advanced Strategies to Improve Outcomes and Reduce Disability in Patients with Multiple Sclerosis

Program Overview

This independent CME/CNE lunch symposium, led by Fred D. Lublin, MD, will analyze therapeutic strategies for improving outcomes and reducing disability in patients with multiple sclerosis (MS). The expert faculty will discuss best practices for early detection and monitoring of disease therapy in the MS patient population. The faculty will debate strategies for selecting and switching therapies in ...
View Course
Micrograph of Invasive urothelial carcinoma high grade. Invasive urothelial carcinoma is a type of Transitional cell carcinoma (TCC, also urothelial cell carcinoma or UCC) and is a type of cancer that develops in the urinary system: the kidney, urinary bladder, and accessory organs. It is the most common type of bladder cancer and cancer of the ureter, urethra, and urachus. Invasive urothelial carcinoma originates from tissue lining the inner surface of these hollow organs - transitional epithelium. It can extend from the kidney collecting system to the bladder. H&E Stain

Scientific Updates for Optimal Outcomes in Patients with Bladder Cancer

Program Overview

This CME/CNE activity will review recent advances in patients with Bladder Cancer as presented at the American Society of Clinical Oncology- Genitourinary Cancers (ASCO GU) 2019 Symposium in San Francisco, CA. Dr. Richard Lee will inform on clinical decision making for patients with bladder cancer by reviewing the science and tumor microenvironment. He will also discuss the latest clinical treatment ...
View Course
Micrography showing rat liver cancer histology, micrograph, photo under microscope, HE staining

Scientific Updates for Improved Outcomes in Patients with Hepatocellular Carcinoma

Program Overview

This CME/CNE program will provide learners with an update regarding treatment and management of patients with hepatocellular carcinoma (HCC) through an interactive panel format. The expert faculty will first set the stage for modern day HCC care, reviewing the science, prevalence and current treatment guidelines. Recent clinical trial data of first line, second line and combination therapies will ...
View Course
Micrograh of small cell carcinoma or also know as small cell lung cancer or oat-call carcinoma is a type of highly malignant cancer. PAP Stain

Best Practices for the Management of Non-Small Cell Lung Cancer

Program Overview

This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC) incorporating data presented at the European Society For Medical Oncology (ESMO) 2018 Conference in Munich, Germany. The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. The faculty will also discuss how ...
View Course
3D Illustration of Human Respiratory System Lungs Anatomy

Scientific Updates for the Advanced Management of Idiopathic Pulmonary Fibrosis

Program Overview

This CME/CNE program will outline recent advances in the treatment and management of  idiopathic pulmonary fibrosis (IPF), incorporating data presented at the 2018 American College of Chest Physicians (CHEST) Annual Meeting in San Antonio, Texas. Three expert faculty, led by Dr. Fernando Martinez, will review and compare recent guidelines/criteria as it relates to therapeutic decision making in the ...
View Course
Heart Attack, man suffering from heart pain. 3D illustration

Scientific Updates to Improve Outcomes in Patients with Pulmonary Arterial Hypertension

Program Overview

This CME activity will discuss recent advances in the treatment and management of patients with pulmonary arterial hypertension (PAH). The expert faculty will provide learners with a scientific update regarding current evidence-based guidelines and appropriate diagnostic strategies. Recent clinical trial data of new and emerging therapeutic options for the treatment of PAH will be reviewed. The faculty will ...
View Course
Loading...